🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
LivaNova PLC (LIVN)
NASDAQ: LIVN · Real-Time Price · USD
92.07
-2.47 (-2.61%)
At close: Nov 19, 2026, 4:00 PM EST
92.07
0.00 (0.00%)
After-hours: Nov 19, 2026, 4:27 PM EST

LivaNova Revenue

LivaNova had revenue of $393.15M in the quarter ending September 30, 2026, with 9.89% growth. This brings the company's total for the last twelve months to $1.51B, up 11.71% year-over-year. In the year 2025, LivaNova had annual revenue of $1.39B with 10.74% growth. That makes LivaNova the 5,987th largest company in the world by revenue and 1,505th in the United States.

Revenue (ttm)
$1.51B
Revenue Growth
+11.71%
P/S Ratio
3.37
Revenue / Employee
$456,641
Employees
3,300
Market Cap
5.07B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Cardiopulmonary 785.39M 56.6%
  • Neuromodulation 592.81M 42.7%
  • Other 9.86M 0.7%

By Geography

Chart
  • United States 739.57M 53.3%
  • Rest of World 379.30M 27.3%
  • Europe (Excluding United Kingdom) 213.28M 15.4%
  • United Kingdom 55.90M 4.0%
Fiscal year ended Dec 31, 2025 See the full LivaNova breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.39B134.62M10.74%
Dec 31, 20241.25B99.89M8.66%
Dec 31, 20231.15B131.74M12.89%
Dec 31, 20221.02B-13.56M-1.31%
Dec 31, 20211.04B101.12M10.82%
Dec 31, 2020934.24M-149.93M-13.83%
Dec 31, 20191.08B-22.79M-2.06%
Dec 31, 20181.11B94.68M9.35%
Dec 31, 20171.01B47.42M4.91%
Dec 31, 2016964.86M673.30M230.93%
Apr 24, 2015291.56M9.54M3.38%
Apr 25, 2014282.01M27.69M10.89%
Apr 26, 2013254.32M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Bruker3.51B
Insulet3.19B
Globus Medical3.14B
Bio-Rad Laboratories2.59B
Bio-Rad Laboratories2.59B
Haemonetics1.38B
Neogen884.00M
iRhythm Holdings854.04M
Revenue Rankings